Scientists dig into Tumor's immune secrets to improve osteosarcoma knowledge
NCT ID NCT03737435
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 29 times
Summary
This study looked at tumor samples from 80 people with localized osteosarcoma who had already received chemotherapy with or without a drug called mifamurtide. Researchers analyzed 770 genes related to the immune system to see how the tumor's environment affects survival. The goal was to gather information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SSD Chemioterapia dei tumori dell'apparato locomotore
Bologna, 40136, Italy
Conditions
Explore the condition pages connected to this study.